The Relation Between Hospital Procedure Volume and Complications of Cardioverter-Defibrillator Implantation From the Implantable Cardioverter-Defibrillator Registry

被引:63
作者
Freeman, James V. [1 ]
Wang, Yongfei [2 ]
Curtis, Jeptha P. [2 ]
Heidenreich, Paul A. [3 ]
Hlatky, Mark A. [1 ]
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA
关键词
defibrillation; epidemiology; morbidity; mortality; PERCUTANEOUS CORONARY INTERVENTIONS; UNITED-STATES; PACEMAKER-IMPLANTATION; PRIMARY ANGIOPLASTY; SURGEON VOLUME; OUTCOMES; MORTALITY; OPERATOR; PHYSICIANS;
D O I
10.1016/j.jacc.2010.07.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We sought to examine the relationship between hospital implantable cardioverter-defibrillator (ICD) implantation volume and procedural complications in a contemporary, representative population. Background Hospitals that perform higher volumes of procedures generally have better clinical outcomes. Methods We examined initial ICD implantations between January 2006 and December 2008 at hospitals participating in the NCDR (National Cardiovascular Data Registry) ICD Registry and evaluated the relationship between hospital annual implant volume and in-hospital adverse outcomes. Results The rate of adverse events declined progressively with increasing procedure volume (p trend < 0.0001). This relationship remained significant (p trend < 0.0001) after adjustment for patient clinical characteristics, operator characteristics, and hospital characteristics. The volume-outcome relationship was evident for all ICD subtypes, including single-chamber (p trend = 0.004), dual-chamber (p trend < 0.0001), and biventricular ICDs (p trend = 0.02). Conclusions Patients who have an ICD implanted at a high-volume hospital are less likely to have an adverse event associated with the procedure than patients who have an ICD implanted at a low-volume hospital. (J Am Coll Cardiol 2010;56:1133-9) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:1133 / 1139
页数:7
相关论文
共 50 条
  • [21] Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort
    Ruwald, Martin H.
    Ruwald, Anne-Christine
    Johansen, Jens Brock
    Gislason, Gunnar
    Nielsen, Jens Cosedis
    Philbert, Berit
    Riahi, Sam
    Vinther, Michael
    Lindhardt, Tommi B.
    EUROPACE, 2019, 21 (08): : 1211 - 1219
  • [22] Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE
    Zeitler, Emily P.
    Friedman, Daniel J.
    Loring, Zak
    Campbell, Kristen B.
    Goldstein, Sarah A.
    Wegermann, Zachary K.
    Schutz, Jane
    Smith, Nicole
    Black-Maier, Eric
    Al-Khatib, Sana M.
    Piccini, Jonathan P.
    HEART RHYTHM, 2020, 17 (03) : 447 - 454
  • [23] Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias
    Raja, Joel
    Guice, Kenneth
    Oberoi, Mansi
    Whitwell, Samantha
    Asbeutah, Abdul Aziz
    Russell, Alex
    Khouzam, Rami N.
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (09)
  • [24] Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention
    Ascoeta, Maria Soledad
    Marijon, Eloi
    Defaye, Pascal
    Klug, Didier
    Beganton, Frankie
    Perier, Marie-Cecile
    Gras, Daniel
    Algalarrondo, Vincent
    Deharo, Jean-Claude
    Leclercq, Christophe
    Fauchier, Laurent
    Babuty, Dominique
    Bordachar, Pierre
    Sadoul, Nicolas
    Boveda, Serge
    Piot, Olivier
    HEART RHYTHM, 2016, 13 (05) : 1045 - 1051
  • [25] Evolution of the Implantable Cardioverter-Defibrillator From Bullets to BBs
    Winkle, Roger A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (23) : 2399 - 2401
  • [26] Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator
    Friedman, Paul
    Murgatroyd, Francis
    Boersma, Lucas V. A.
    Manlucu, Jaimie
    O'Donnell, David
    Knight, Bradley P.
    Clementy, Nicolas
    Leclercq, Christophe
    Amin, Anish
    Merkely, Bela P.
    Birgersdotter-Green, Ulrika M.
    Chan, Joseph Y. S.
    Biffi, Mauro
    Knops, Reinoud E.
    Engel, Greg
    Carvajal, Ignacio Munoz
    Epstein, Laurence M.
    Sagi, Venkata
    Johansen, Jens B.
    Sterlinski, M.
    Steinwender, Clemens
    Hounshell, Troy
    Abben, Richard
    Thompson, Amy E.
    Wiggenhorn, Christopher
    Willey, Sarah
    Crozier, Ian
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (14) : 1292 - 1302
  • [27] Antitachycardia pacing for reduction of implantable cardioverter-defibrillator shocks
    Cantillon, Daniel J.
    Wilkoff, Bruce L.
    HEART RHYTHM, 2015, 12 (06) : 1370 - 1375
  • [28] Is Anyone Too Old for an Implantable Cardioverter-Defibrillator?
    Heidenreich, Paul A.
    Tsai, Vivian
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (01): : 6 - 8
  • [29] Predictors of early mortality in implantable cardioverter-defibrillator recipients
    Stein, Kenneth M.
    Mittal, Suneet
    Gilliam, F. Roosevelt
    Gilligan, David M.
    Zhong, Qian
    Kraus, Stacia Merkel
    Meyer, Timothy E.
    EUROPACE, 2009, 11 (06): : 734 - 740
  • [30] Lessons from the failure and recall of an implantable cardioverter-defibrillator
    Hauser, RG
    Maron, BJ
    CIRCULATION, 2005, 112 (13) : 2040 - 2042